本栏目为您提供冠心病、高血压 、血脂异常、心律失常、瓣膜性心脏病、心肌梗塞、先心病 、肺栓塞、心肌病、心力衰竭、肺动脉高压、外周心血管病、糖尿病、脑卒中、代谢综合征、急性冠脉综合征、心血管综合 相关幻灯课件,您可以免费下载使用
点击显示 收起
文件类型:PPT | 文件大小:53KB | 上传时间:06-02-20
摘要:新的CHD危险因素及评估方法Magnitude of the Burden—Causes of Death in the United StatesDeaths in 1996 (thousands)CVDCancerAccidentsHIV/AIDS959。 1999 Heart and Stroke Statistical Update。Economic Di...
文件类型:PPT | 文件大小:56KB | 上传时间:06-02-20
摘要:调脂治疗的新方法Frequency Distribution of Serum Homocysteine in Healthy Men and WomenFrequency %Serum Homocysteine Concentration (。mol/L)Factors Influencing Serum Homocysteine LevelsGeneticCystath...
文件类型:PPT | 文件大小:42KB | 上传时间:06-02-20
摘要:贝特类药物在血脂治疗中的作用COOCCH3COOCHCH3CH3ClCH3OCCH3COOC2H5CH3ClCH3CH3OCH3COOHCH3CFenofibrateClofibrateGemfibrozilEffect of Drugs on LDL-C LevelsEffect of Drugs on Triglyceride and HDL-C Levels...
文件类型:PPT | 文件大小:127KB | 上传时间:06-02-20
摘要:HDL和LDL风险评估与治疗The Pyramid of Recent Trials Relative Size of the Various Segments of the Population4SCAREWOSCOPSAFCAPS/TexCAPSLIPIDAir Force/Texas Coronary Atherosclerosis Prevention Study (...
文件类型:PPT | 文件大小:30KB | 上传时间:06-02-20
摘要:HDL的药物治疗NCEP ATP-II Cutpoints for TG and HDL-CParametermg/dLNormal TG 200Borderline-high TG200–400High TG400–1,000Very high TG 1,000Low HDL-C 35High (protective) HDL-C。 60Expert Panel on De...
文件类型:PPT | 文件大小:25KB | 上传时间:06-02-20
摘要:生活方式和饮食控制对HDL-C的影响HDL and Coronary Heart DiseaseEffects of Lifestyle and Dietary Modification on HDL-C LevelsLifestyle ChangesWeight lossSmoking cessationExerciseWeight and HDL-C Inver...
文件类型:PPT | 文件大小:43KB | 上传时间:06-02-20
摘要:HDL的临床试验HDL and Coronary Heart DiseaseAngiographic and Clinical Event TrialsAngiographic Trials of Combination TherapyCholesterol Lowering Atherosclerosis Study (CLAS)1Diet and niacin + colest...
文件类型:PPT | 文件大小:33KB | 上传时间:06-02-20
摘要:HDL代谢的生理学和病理学意义HDL and Coronary Heart DiseasePhysiology and Pathophysiology of HDL MetabolismStructure of HDL ParticleA-IA-IA-IIA-I, A-II = apolipoprotein A-I, A-II。 TG = triglycerides...
文件类型:PPT | 文件大小:522KB | 上传时间:06-02-20
摘要:新治疗目标:HDLHDL as a Therapeutic Target Daniel J。100160220Risk of CHDLow HDL-C is an Independent Predictor of CHD Risk Even When LDL-C is LowHDL-C (mg/dL)LDL-C (mg/dL)25Gordon T et al。456585AT...
文件类型:PPT | 文件大小:33KB | 上传时间:06-02-20
摘要:HDL和冠心病HDL and Coronary Heart DiseaseEpidemiology of CHDHDL-C Distribution in US AdultsRF = risk factorsData from NHANES III, 1988–1994HDL-C (mg/dL) 3535– 4545– 60。 60CHD0246810121416。 2 R...
文件类型:PPT | 文件大小:635KB | 上传时间:06-02-20
摘要:代谢综合征Update on the Metabolic Syndrome Steven Haffner, MDExpert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults。Metabolic Syndrome Increases Risk for CHD and ...
文件类型:PPT | 文件大小:90KB | 上传时间:06-02-20
摘要:胰岛素抵抗、糖尿病与冠心病Epidemiology of Insulin Resistance, Diabetes Mellitus, and Coronary Heart Disease Steven Haffner, MDAdapted from World Health Organization。 Definition, Diagnosis and Clas...
文件类型:PPT | 文件大小:49KB | 上传时间:06-02-20
摘要:糖尿病与动脉粥样硬化Diabetic Dyslipidemia and Atherosclerosis Henry Ginsberg, MDInterrelation Between Atherosclerosis and Insulin ResistanceHypertensionObesityHyperinsulinemiaDiabetesHypertriglycer...
文件类型:PPT | 文件大小:85KB | 上传时间:06-02-20
摘要:糖尿病脂代谢紊乱的治疗与临床指南Clinical Trials and Guidelines for Lipid Management in the Diabetic Patient Steven Haffner, MDUKPDS DesignAimTo determine whether intensified blood glucose control, ...
文件类型:PPT | 文件大小:141KB | 上传时间:06-02-20
摘要:糖尿病心血管疾病的非降脂治疗与临床评价Clinical Evaluation and Nonlipid Treatment of Coronary Artery Disease in the Diabetic Patient Richard Nesto, MDPrevalence of Asymptomatic CAD in Diabetes Melli...
文件类型:PPT | 文件大小:2287KB | 上传时间:06-02-20
摘要:脂蛋白临床LIPID: Reduction in Nonfatal MI and CHD Death Risk Stratified by Diabetic Status-19-25302520151050With diabetesWithout diabetes(n=782)(n=8,232)LIPID Study Group。%0123CHD mortality (per 1...
文件类型:PPT | 文件大小:479KB | 上传时间:06-02-20
摘要:糖尿病脂代谢紊乱ATP III: Management of Diabetic Dyslipidemia Primary target of therapy: identification of LDL-C。 goal for persons with diabetes: 100 mg/dL Therapeutic options:LDL-C 100–129 mg/dL:...
文件类型:PPT | 文件大小:2048KB | 上传时间:06-02-20
摘要:血脂领域重大循证研究汇总Gould AL et al。Clinical Benefits of Cholesterol ReductionA recent meta-analysis of 38 trials demonstrated that for every 10% reduction in TCCHD mortality decreased by 15% (...
文件类型:PPT | 文件大小:535KB | 上传时间:06-02-20
摘要:血脂治疗与临床指南JNC 7: Classification and Management of Blood Pressure for Adults**Treatment determined by highest BP category 。Initial combined therapy should be used cautiously in those at ris...
文件类型:PPT | 文件大小:179KB | 上传时间:06-02-20
摘要:Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults。Treatment Categories, LDL-C Goals and Cutpoints* 100–129 mg/dL = after TLC, consider statin, niacin, or fi...
文件类型:PPT | 文件大小:287KB | 上传时间:06-02-20
摘要:ATPIII:识别和治疗高危患者的新方法ATP III: New Approaches in Identifying and Treating High-Risk Patients Steven Haffner, MDHospitalization for MI Has Not DeclinedHospitalization for MI (per 1,000)*...
文件类型:PPT | 文件大小:1006KB | 上传时间:06-02-20
摘要:SYNERGY研究Presenters’ Disclosure Information: Relationships Related to this PresentationResearch Grants and/or Consultant fees:Mahaffey: Aventis, AstraZeneca, Berlex, Lilly, Daiichi, Millennium, ...
文件类型:PPT | 文件大小:122KB | 上传时间:06-02-20
摘要:STRATUS-US研究Smoking Cessation in Smokers Motivated to Quit Presented atAmerican College of CardiologyScientific Sessions 2004Presented by Dr。 Robert Anthenelli STRATUS-US TrialRimonabantA select...
文件类型:PPT | 文件大小:31KB | 上传时间:06-02-20
摘要:SCD-HeFT研究Sudden Cardiac Death in Heart Failure TrialPresented atAmerican College of CardiologyScientific Sessions 2004Presented by Dr。 BardySCD-HeFTEndpoints (median 45。5 months):All-cause mor...
文件类型:PPT | 文件大小:111KB | 上传时间:06-02-20
摘要:RIO-LIPIDS研究Rimonabant in Obesity Presented atAmerican College of CardiologyScientific Sessions 2004Presented by Dr。 Jean-Pierre Despres RIO LIPIDS TrialRimonabantA selective cannabinoid type 1 ...
文件类型:PPT | 文件大小:505KB | 上传时间:06-02-20
摘要:PROVE IT研究PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22)Disclosure Statement: Dr。 Does “intensive” LDL-C lowering to an average of 65 mg/dL achieve a greater reduction ...